|
The global pharmaceutical biotech market continues to experience high growth, with developers ranging from major pharmaceutical companies to specialist pharmaceutical firms. Significant R&D efforts and innovative new treatments will lead to further expansion of the pharma biotech market. This new report – Global Pharmaceutical Biotech Market 2010-2025 – explains why that market will expand, revealing where the most exciting developments will lie.
This report examines markets for the following therapy classes:
• Oncology
• Insulins
• Immunosuppressive agents
• Autoimmune agents
• Erythropoietin products
• Immunostimulating agents
• Interferons
• Pure vaccines
• Blood coagulation factors
• Growth hormones.
Which therapy classes will lead the pharma biotech market in future? Where will the best commercial opportunities lie from 2010 onwards? What are the most-crucial drivers and restraints in this increasingly-important market? This report will provide you with the information that you need to understand current trends and future directions in the global biopharma sector, seeing how it will further bolster the global pharma industry and market. In particular, we discuss prospects for the following products:
• Enbrel
• Remicade
• Avastin
• Humira
• MabThera
• Herceptin
• Lantus
• Neulasta
• Glivec
• Epogen.
Comprehensive analysis of the global biopharma market:
Global Pharmaceutical Biotech Market 2010-2025 critically examines that sector through a comprehensive review of information sources and original analysis. The report provides detailed sales forecasts, market share analyses, discussions of pipeline developments and analyses of commercial drivers and restraints, including a SWOT analysis. There are over 100 tables and figures included. The result is a comprehensive market- and industry-centred study, with detailed analyses to benefit your work.
Why you should buy Global Pharmaceutical Biotech Market 2010-2025?
In this report you will receive the following benefits in particular:
• You will assess the current market for pharma biotech products
• You will review the overall pharma biotech market, including a global sales forecast for 2010 to 2025
• You will receive sales forecasts for the ten leading biotech therapy classes from 2010 to 2025, with detailed discussions
• You will receive sales forecasts for the leading products in this market from 2010 to 2025, with detailed discussions of market potential and competition
• You will receive sales forecasts for leading geographical markets from 2010 to 2025, with informed discussion
• You will examine commercial drivers and restraints in depth, exploring their significance
• You will discover the most-exciting pipeline developments in the sector, across a range of therapy classes.
• Market growth, novel technologies and expansion into new therapeutic areas - our latest report examines the significant technological and commercial opportunities in the global biopharma market.
Nobody with an interest in the pharmaceutical biotech market should overlook this new study. We predict that total revenues will increase throughout our forecast period, 2010 to 2025. With new and increasingly innovative products and a strong pipeline, this crucial pharma sector holds high potential. Do you want to harness those opportunities?
|
현재위치 : 
